Congenica Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Congenica Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11264
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug development, and support clinical trials, among others. Congenica offers services such as clinical and genomic data, clinical reporting, and variant interpretation, among others. The company’s clinical reporting secures share access of genotype and phenotype and generates customisable reports. It partners with clinical research and healthcare providers, diagnostic, and pharmaceutical companies and charities and patient advocacy groups. Congenica is headquartered in Cambridge, the UK.

Congenica Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Congenica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Congenica Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Congenica Raises USD10 Million in Series B Financing 11
Congenica Raises USD3.2 Million in Series A Financing 12
Congenica Raises USD1.56 Million in Seed Financing 13
Partnerships 14
Congenica Enters into Agreement with GenomOncology 14
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 15
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 16
Congenica Ltd – Key Competitors 17
Congenica Ltd – Key Employees 18
Congenica Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Aug 28, 2018: Congenica names Wendy Britten as Chief Financial Officer 20
Jan 25, 2018: Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business 21
Jan 17, 2017: Congenica appoints new chief business officer 22
Jan 17, 2017: Congenica Expands in North America with Strategic Appointment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Congenica Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Congenica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Congenica Raises USD10 Million in Series B Financing 11
Congenica Raises USD3.2 Million in Series A Financing 12
Congenica Raises USD1.56 Million in Seed Financing 13
Congenica Enters into Agreement with GenomOncology 14
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 15
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 16
Congenica Ltd, Key Competitors 17
Congenica Ltd, Key Employees 18

List of Figures
Congenica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Congenica Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • Sberbank Rossii:企業の戦略・SWOT・財務情報
    Sberbank Rossii - Strategy, SWOT and Corporate Finance Report Summary Sberbank Rossii - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Goodman Fielder Pty Ltd:企業の戦略・SWOT・財務情報
    Goodman Fielder Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Goodman Fielder Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pinnacle Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia International Corp is a drug development company that develops and markets photodynamic therapy products. The company offers products such as OPTIGUIDE PI, ETHYOL PI, PHOTOFRIN PI, and DIOMED products, among others. Its O …
  • Disproquima S.A.:企業の戦略・SWOT・財務情報
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Harsoria Healthcare Pvt Ltd:企業の戦略的SWOT分析
    Harsoria Healthcare Pvt Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Antisense Therapeutics Ltd (ANP):企業の財務・戦略的SWOT分析
    Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Exchange Income Corporation:企業の戦略・SWOT・財務情報
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • M3 Midstream LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary M3 Midstream LLC (Momentum) is an independent oil and gas company that offers midstream oilfield services. The company provides services such as gas processing and treating, wellhead gathering, dehydration, fractionation, compression, and storage services for natural gas and natural gas liqu …
  • Didi Chuxing Co Ltd:企業の戦略的SWOT分析
    Didi Chuxing Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報
    Summary TechnoPhage SA (TechnoPhage) is a biopharmaceutical company that offers contract research and development of new molecules. The company conducts its research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development servi …
  • Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報
    Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form o …
  • Combined Motor Holdings Ltd.:企業の戦略・SWOT・財務情報
    Combined Motor Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Combined Motor Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ARC Resources Ltd (ARX):石油・ガス:M&Aディール及び事業提携情報
    Summary ARC Resources Ltd (ARC) is an energy company, which carries out exploration, development and production of conventional crude oil and natural gas reserves. Its produces light and medium crude oil, heavy oil, tight oil, condensate, natural gas and natural gas liquids. The company’s operations …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • Shinva Medical Instrument Co Ltd (600587):医療機器:M&Aディール及び事業提携情報
    Summary Shinva Medical Instrument Co., Ltd. (Shinva Medical) manufactures and markets medical instruments and environmental protection equipment for various healthcare markets. The company’s product portfolio includes sterilizers, radiotherapy equipment, digital diagnosis equipment, surgical instrum …
  • Aerovironment Inc:企業の戦略・SWOT・財務分析
    Aerovironment Inc - Strategy, SWOT and Corporate Finance Report Summary Aerovironment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EnQuest Plc (ENQ):石油・ガス:M&Aディール及び事業提携情報
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company’s assets include producing oil fields, portfolio of discoveries, and new developments. Its oil and gas exploration assets are located in the UK North Sea and also have presence in oil basins o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆